CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 105 filers reported holding CYTEK BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $152,060 | +32.4% | 17,028 | +50.5% | 0.01% | +14.3% |
| Q1 2023 | $114,878 | -41.3% | 11,318 | -22.1% | 0.01% | -41.7% |
| Q4 2022 | $195,652 | -6.8% | 14,525 | +1.8% | 0.01% | -20.0% |
| Q3 2022 | $210,000 | +40.9% | 14,270 | +22.7% | 0.02% | +36.4% |
| Q2 2022 | $149,000 | +40.6% | 11,626 | +5.4% | 0.01% | +37.5% |
| Q1 2022 | $106,000 | -30.7% | 11,030 | +4.5% | 0.01% | -27.3% |
| Q4 2021 | $153,000 | -27.8% | 10,560 | +13.3% | 0.01% | -26.7% |
| Q3 2021 | $212,000 | – | 9,323 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |